Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The Nr4a nuclear hormone receptors are transcriptionally upregulated in response to antigen recognition by the T cell receptor (TCR) in the thymus and are implicated in clonal deletion, but the mechanisms by which they operate are not clear. Moreover, their role in central tolerance is obscured by redundancy among the Nr4a family members and by their reported functions in Treg generation and maintenance. Here we take advantage of competitive bone marrow chimeras and the OT-II/RIPmOVA model to show that Nr4a1 and Nr4a3 are essential for the upregulation of Bcl2l11/BIM and thymic clonal deletion by self-antigen. Importantly, thymocytes lacking Nr4a1/3 acquire an anergy-like signature after escaping clonal deletion and Treg lineage diversion. We further show that the Nr4a family helps mediate a broad transcriptional program in self-reactive thymocytes that resembles anergy and may operate at the margins of canonical thymic tolerance mechanisms to restrain self-reactive T cells after thymic egress.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742425PMC
http://dx.doi.org/10.1038/s41467-025-55839-5DOI Listing

Publication Analysis

Top Keywords

clonal deletion
16
nr4a1 nr4a3
8
nr4a family
8
nr4a3 redundantly
4
redundantly control
4
clonal
4
control clonal
4
deletion
4
deletion contribute
4
contribute anergy-like
4

Similar Publications

Background: Antibody-drug conjugates (ADCs) combine targeted monoclonal antibodies with cytotoxic payloads and are an emerging modality in systemic cancer therapy. Thirteen ADCs are Food and Drug Administration approved, with many more in development. However, design and use remain challenging, with issues including on/off-target toxicity, resistance from prior exposure to payload classes, and optimal target/payload selection.

View Article and Find Full Text PDF

Hepatocytes (HCs), which share a developmental origin with cholangiocytes (CCs), have the capacity to undergo reparative reprogramming into CCs in response to liver injury and, under specific conditions, can also transform malignantly into cholangiocarcinoma (CCA). However, the molecular mechanisms governing HC plasticity in liver diseases remain poorly understood. In this study, we investigated the role of , an oncofetal transcription factor, in both malignant and regenerative HC fate transitions toward the biliary lineage.

View Article and Find Full Text PDF

Mast cell (MC) disorders result from inappropriate release of mediators and/or excessive accumulation of MCs, leading to symptoms of various organs and systems. Clonal MC disorders are defined by the presence of phenotypically aberrant and/or KIT-mutated MCs, and if aggregates of MCs are detectable, are designated as mastocytosis. Systemic mastocytosis (SM) affects mainly the bone marrow, with or without skin involvement.

View Article and Find Full Text PDF

Chromoplexy.

Methods Mol Biol

August 2025

Unit of Chromosomal Genetics and Research Platform Chromostem, Department of Molecular Genetics and Cytogenomics, Site Unique de Biologie (SUB), Montpellier CHU, Montpellier Cedex 5, France.

Chromoplexy is a massive and complex rearrangement mechanism, occurring during a single cell event and characterized by the formation of chain rearrangements affecting multiple chromosomes. This can lead to the formation of fusion genes and the simultaneous disruption of several genes. Chromoplexy was first identified in prostate cancers, but it is now being observed in various cancers where gene fusions take place.

View Article and Find Full Text PDF

Upon antigenic stimulation, CD4T cells undergo clonal expansion elevating their bioenergetic demands and utilization of nutrients like glucose and glutamine. The nuclear factor erythroid-2-related factor 2 (Nrf2) is a well-known regulator of oxidative stress, but its involvement in modulating the metabolism of CD4T cells remains unexplored. We report that Nrf2 protein levels are temporally regulated in activated CD4T cells, with elevated expression during early activation followed by a decline.

View Article and Find Full Text PDF